← 返回

肿瘤相关 T 细胞受体信号传导的破坏:跨癌症的启示及其对 CLL 的意义

英文原题:Tumor-associated disruption of T cell receptor signaling: lessons across cancers with implications for CLL.

查看英文原题

Tumor-associated disruption of T cell receptor signaling: lessons across cancers with implications for CLL.

PubMed 2025/11/14(内容时间) Leuk Lymphoma Q3 · IF 2.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

在慢性淋巴细胞白血病(CLL)中,T细胞功能障碍是一个标志性特征,包括增殖受损、细胞毒性降低、免疫突触形成缺陷以及代谢耗竭。虽然这些改变已被充分描述,但其潜在机制仍不完全清楚。相比之下,在实体瘤免疫治疗领域,广泛的研究已经对肿瘤如何逃逸T细胞免疫产生了详细的机制性见解,特别是通过在多个层面干扰T细胞受体(TCR)信号传导。本综述探讨实体肿瘤学中发现的T细胞功能障碍机制是否能够为理解CLL中的T细胞衰竭提供信息。通过将CLL中的TCR缺陷与实体瘤的见解相对照,我们确定了CLL中T细胞衰竭的机制性解释,这些解释值得进一步研究。这些包括非经典检查点信号传导、抑制性磷酸酶的募集以及激活信号传导的传播受损。理解这些通路可能有助于合理设计针对CLL的下一代免疫疗法。

展开英文摘要原文

In chronic lymphocytic leukemia (CLL), T cell dysfunction is a hallmark feature and includes impaired proliferation, reduced cytotoxicity, defective immunological synapse formation, and metabolic exhaustion. While these alterations have been well described, the underlying mechanisms remain incompletely understood. By contrast, in the field of solid tumor immunotherapy, extensive research has yielded detailed mechanistic insights into how tumors evade T cell immunity, particularly by interfering with T cell receptor (TCR) signaling at multiple levels.

This review examines whether the mechanisms of T cell dysfunction uncovered in solid oncology can inform our understanding of T cell failure in CLL. By aligning TCR defects in CLL with insights from solid tumors, we identify mechanistic explanations for T cell failure in CLL that warrant further investigation. These include non-canonical checkpoint signaling, recruitment of inhibitory phosphatases, and impaired propagation of activation signals. Understanding these pathways may enable rational design of next-generation immunotherapies for CLL.

论文信息

作者
Lopez-Sanchez C、van Bruggen JAC、Kater AP
单位
Department of Hematology, University of Amsterdam, Amsterdam, the Netherlands.Netherlands
文献类型
综述
期刊
Leukemia & lymphoma2026 Jan
原文标识
PubMed 41236817 · DOI 10.1080/10428194.2025.2587786